Search This Blog

Thursday, November 19, 2026

Novartis outlook disappoints

 Novartis forecasts 5% annual sales growth through 2031 and a core operating margin of at least 40% by 2029.

https://finviz.com/stock?t=NVS&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.